COURSE CREDITS & HOURS
16 AMA PRA Category 1 Credits™16 ACPE Credits
16.0 Contact Hours
16 CE Credits for Psychologists
16 ASWB ACE Credits
COURSE FEES
TARGET AUDIENCE
PROGRAM PURPOSE
- Caring for perimenopause and menopause patients in 2023: diagnosis, common symptoms, treatments
- Understand the physiology of perimenopause and menopause >li>Utilize the 2022 Position Statement of the North American Menopause Society to inform care of midlife women experiencing perimenopause and menopause
- 51 is Getting Younger all the Time: maximizing longterm health in menopause
- Explain the differences in cardiac response to HT in younger menopausal women versus older menopausal women
- Individualize care for symptomatic menopausal women with medical comorbidities
- Consider the effect of hormone therapy in promoting bone health
- Mood and Menopause: diagnosis and treatment of Perimenopausal Mood Instability
- Differentiate perimenopausal mood instability (PMI) from major depressive disorder (MDD) and generalized anxiety disorder (GAD)
- List effective treatments for PMI including psychological and pharmacological approaches
- I CanÂ’t Sleep and IÂ’m Getting Fat: evaluating and treating the twin scourges of midlife
- Recognize the signs and symptoms of common sleep disorders and list behavioral and pharmacologic treatments for them
- Define the common disease of obesity and list effective psychotherapeutic and medical treatments
- Nutrition and the Aging Brain: can we prevent dementia?
- Understand how nutrition impacts brain changes with aging
- B. Describe what we can learn from the Blue Zones and other research about nutrition and healthy aging brain
- Develop skills to talk with patients and ensure a brain-healthy diet is accessible to them
- Beyond Masters and Johnson: models of female sexuality
- Describe the four major models of female sexual behavior
- Utilize the four models to counsel patients with concerns regarding their sexual function
- Female Sexual Dysfunction: disorders of desire, arousal, and orgasm
- Be familiar with the DSM-V diagnostic categories of female sexual dysfunction
- Utilize the ISSWSH Process of Care to manage hypoactive sexual desire disorder
- List at least 2 behavioral and 2 pharmacological treatment options for female sexual dysfunction
- When Sex Hurts: causes and treatments of dyspareunia
- Utilize a stepwise approach to diagnosis of dyspareunia
- Explain and initiate treatment when appropriate
- Reproductive Psychiatry: 2023 Update and Overview
- Describe key parameters of the field Reproductive Psychiatry in 2023 and why it is relevant today
- Define the role of Neuroactive Steroids (NAS) in both the etiology and the treatment of psychiatric conditions in the female patient
- Depression Across the Female Reproductive Cycle 1: Focus on PMDD, PME and Menopause
- Identify the hormonal effect on depression in the non pregnant female
- Describe diagnostic criteria for PMDD and hormonal and non hormonal interventions
- Depression Across the Female Reproductive Cycle 2: Focus on Perinatal Depression
- Recognize unique features to consider in the diagnosis and treatment of perinatal depression
- Identify and become comfortable using with at least three screening tools for PMADs
- List several biopsychosocial risk factors for PMADs
- Beyond Postpartum Depression: Diagnosis and Treatment of Perinatal Anxiety Disorders
- Identify which anxiety disorders most commonly present in the perinatal period
- Describe the role of estrogen, progesterone and oxytocin in the etiology of these disorders
- Bipolar Disorder in Women: Meeting the Challenge 1: Managing Bipolar Disorder in the non-pregnant female patient
- Describe evidence-based management of bipolar disorder in women
- Identify how hormonal treatment may impact course of disorder as well as treatment options
- Bipolar Disorder in Women 2: Meeting the Challenge 2: Managing Bipolar Disorder during Pregnancy and Postpartum
- Describe options for treatment of bipolar disorder during pregnant and postpartum to optimize safety of mother and infant
- Discuss with your patient the risk/benefit ratio of the use of psychotropics during the perinatal period
- Diagnose sexual dysfunction in females (FSD) using DSM-5 terminology.
- Identify common barriers in identification of FSD in clinical settings
- Develop a treatment plan for women with FSD
- Evidence Based Approaches to Female Patients with Low Libido
- Describe 3 behavioral interventions for the female patient with low libido Describe both hormonal and non hormonal treatments for low libido in females